===
EQS Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back Program - 5th Interim
Announcement, concurrently completion announcement
Share Buy-Back Program - 5th Interim Announcement, concurrently completion announcement
2024-04-29 / 14:55 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014
(MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 5th Interim Announcement, concurrently completion
announcement
In the period from April 22, 2024 until and including April 26, 2024, CompuGroup Medical SE & Co. KGaA has bought back
an aggregate number of 119,464 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had
been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start
on March 26, 2024.
The aggregate number of shares bought back each day during the period from April 22, 2024 until and including April 26,
2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:

Date          Aggregate volume (number of no-par value Volume-weighted average price (in EUR, excluding ancillary costs 
shares)                                  and charges) 
April 22,     14,500                                   29.0938 

2024
April 23, 32,692 29.0912
2024
April 24, 33,172 29.1274
2024
April 25, 33,558 28.2753
2024
April 26, 5,542 28.2623
2024
Total: 119,464 28.8339 The maximum number of shares to be bought back under the share buy-back program has been reached on April 26, 2024 and the share buy-back program is therefore completed. The purchase price per share paid for the 500,000 shares bought up to the increase and extension of the share buy-back program amounted to an average of EUR 29.2554. Detailed information about the transactions are published on the company's website under https://www.cgm.com/corp_en/ company/ir-en/share.html . The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, April 29, 2024 CompuGroup Medical SE & Co. KGaA The general partner
===
-----------------------------------------------------------------------------------------------------------------------

2024-04-29 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      CompuGroup Medical SE & Co. KGaA 

Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

End of News EQS News Service
===
1891967 2024-04-29 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1891967&application_name=news

END) Dow Jones Newswires

April 29, 2024 08:55 ET (12:55 GMT)